Ataxia-telangiectasia: from a rare disorder to a paradigm for cell signalling and cancer
The DOI matches its Crossref record; 125 of the 126 references it cites were found in a registry or an index.
Abstract
First described over 80 years ago, ataxia-telangiectasia (A-T) was defined as a clinical entity 50 years ago. Although not encountered by most clinicians, it is a paradigm for cancer predisposition and neurodegenerative disorders and has a central role in our understanding of the DNA-damage response, signal transduction and cell-cycle control. The discovery of the protein A-T mutated (ATM) that is deficient in A-T paved the way for rapid progress on understanding how ATM functions with a host of other proteins to protect against genome instability and reduce the risk of cancer and other pathologies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“p53 (TP53), which is a major target of the PI3K-related protein kinases (PI3K) ATM and ATR and that plays a pivotal role in DDR 5”
From Senescence from G2 arrest, revisited (2015) · cites this paper as [5]
In the citing paper
“ATM is a defective gene in Ataxia-telangiectasia (A-T), an autosomal recessive disorder with early onset progressive cerebellar ataxia, oculocutaneous telangiectasia, and lymphoid tumor susceptibility [48, 49].”
From Functional interplay between ATM/ATR-mediated DNA damage response and DNA repair pathways in oxidative stress (2014) · cites this paper as [48]
Citations
Cites
DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation
Bakkenist, C. J., & Kastan, M. B. (2003) · Nature · doi:10.1038/nature01368 · Cited by 3,466 · cited 1×
“Indeed, chloroquine and other agents that alter chromatin structure can cause partial activation of ATM in the absence of DNA DSB”
BackgroundATM and ATR Substrate Analysis Reveals Extensive Protein Networks Responsive to DNA Damage
Matsuoka, S., Ballif, B. A., Smogorzewska, A., McDonald, E. R., Hurov, K. E., Luo, J., Bakalarski, C. E., Zhao, Z., Solimini, N., Lerenthal, Y., et al. (2007) · Science · doi:10.1126/science.1140321 · Cited by 3,075 · cited 1×
“ATM has multiple substrates — indeed, recent proteomic analysis of phosphoproteins induced by DNA damage suggest that the ATM and ATR network might have as many as 700 substrate”
BackgroundKastan, M. B., Zhan, Q., El-Deiry, W. S., Carrier, F., Jacks, T., Walsh, W. V., Plunkett, B. S., Vogelstein, B., & Fornace, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90593-2 · Cited by 3,047 · cited 1×
“This was not surprising, because the stabilization and activation of p53 was defective in A-T cells, and these cells were also characterized by a defective G1–S checkpoint, in which p53 has a central rol”
BackgroundA Single Ataxia Telangiectasia Gene with a Product Similar to PI-3 Kinase
Savitsky, K., Bar-Shira, A., Gilad, S., Rotman, G., Ziv, Y., Vanagaite, L., Tagle, D. A., Smith, S., Uziel, T., Sfez, S., et al. (1995) · Science · doi:10.1126/science.7792600 · Cited by 2,785
Self-citationActivation of the ATM Kinase by Ionizing Radiation and Phosphorylation of p53
Canman, C. E., Lim, D.-S., Cimprich, K. A., Taya, Y., Tamai, K., Sakaguchi, K., Appella, E., Kastan, M. B., & Siliciano, J. D. (1998) · Science · doi:10.1126/science.281.5383.1677 · Cited by 2,042
Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions
Gorgoulis, V. G., Vassiliou, L.-V. F., Karakaidos, P., Zacharatos, P., Kotsinas, A., Liloglou, T., Venere, M., DiTullio, R. A., Kastrinakis, N. G., Levy, B., et al. (2005) · Nature · doi:10.1038/nature03485 · Cited by 2,009
Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints
Bartkova, J., Rezaei, N., Liontos, M., Karakaidos, P., Kletsas, D., Issaeva, N., Vassiliou, L.-V. F., Kolettas, E., Niforou, K., Zoumpourlis, V. C., et al. (2006) · Nature · doi:10.1038/nature05268 · Cited by 1,986
An Oncogene-Induced DNA Damage Model for Cancer Development
Halazonetis, T. D., Gorgoulis, V. G., & Bartek, J. (2008) · Science · doi:10.1126/science.1140735 · Cited by 1,851 · cited 1×
“DNA breaks per se can also be beneficial in that they activate a DNA-damage response in pre-cancerous cells, thereby establishing a barrier to tumour progressio”
BackgroundATR: an essential regulator of genome integrity
Cimprich, K. A., & Cortez, D. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2450 · Cited by 1,798
Enhanced Phosphorylation of p53 by ATM in Response to DNA Damage
Banin, S., Moyal, L., Shieh, S.-Y., Taya, Y., Anderson, C. W., Chessa, L., Smorodinsky, N. I., Prives, C., Reiss, Y., Shiloh, Y., et al. (1998) · Science · doi:10.1126/science.281.5383.1674 · Cited by 1,797
Research works printed but not linked: 2
- Syllaba, K. & Henner, K. Contribution a l'independence de l'athetose double idiopathique et congenitale. Atteinte familiale, syndrome dystrophique, signe de reseau vasculaire conjonctival, integrite psychique. Rev. Neurol. 1, 541–562 (1926) (in French).
- Digweed, M., Reis, A. & Sperling, K. Nijmegen breakage syndrome: consequences of defective DNA double strand break repair. Bioessays 21, 649–656 (1999). · doi:10.1002/(sici)1521-1878(199908)21:8<649::aid-bies4>3.0.co;2-o
Cited by
Items 501–600 of 898
Dong, C., Wang, X., Sun, L., Zhu, L., Yang, D., Gao, S., Zhang, W., Ling, B., Liang, A., Gao, Z., et al. (2022) · Stem Cell Research · doi:10.1016/j.scr.2021.102618 · Cited by 16
Yu, J. H., Cho, S. O., Lim, J. W., Kim, N., & Kim, H. (2015) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2015.01.002 · Cited by 16
Chen, Y., Wang, C., Wei, M., Tzeng, Y.-S., Lan, K.-H., Cheng, A., & Kuo, S. (2019) · Cancers · doi:10.3390/cancers11081204 · Cited by 19
Pot1a Prevents Telomere Dysfunction and ATM-Dependent Neuronal Loss
Lee, Y., Brown, E. J., Chang, S. S., & McKinnon, P. J. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.4245-13.2014 · Cited by 17
Mode of ATM-dependent suppression of chromosome translocation
Yamauchi, M., Suzuki, K., Oka, Y., Suzuki, M., Kondo, H., & Yamashita, S. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.11.006 · Cited by 18
DNA damage-induced inflammation and nuclear architecture
Stratigi, K., Chatzidoukaki, O., & Garinis, G. A. (2016) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2016.09.008 · Cited by 18
Jeong, I., Patel, A. Y., Zhang, Z., Patil, P. B., Nadella, S., Nair, S., Ralston, L., Hoormann, J. K., & Fisher, J. S. (2009) · Acta Physiologica · doi:10.1111/j.1748-1716.2009.02069.x · Cited by 16
MAD2B-mediated cell cycle reentry of podocytes is involved in the pathogenesis of FSGS
Bao, D., Su, H., Lei, C., Tang, H., Ye, C., Xiong, W., He, F.-F., Lin, J., Hammes, H., & Zhang, C. (2021) · International Journal of Biological Sciences · doi:10.7150/ijbs.62238 · Cited by 16
Dharmaiah, S., Malgulwar, P. B., Johnson, W. E., Chen, B., Sharin, V. G., Whitfield, B. T., Alvarez, C., Tadimeti, V., Farooqi, A. S., & Huse, J. T. (2024) · Neuro-Oncology · doi:10.1093/neuonc/noae248 · Cited by 16
The neuro-glial-vascular interrelations in genomic instability symptoms
Barzilai, A. (2011) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2011.06.001 · Cited by 16
Absence of Wip1 partially rescues Atm deficiency phenotypes in mice
Darlington, Y. F., Nguyen, T.-A., Moon, S.-H., Herron, A., Rao, P., Zhu, C., Lu, X., & Donehower, L. A. (2011) · Oncogene · doi:10.1038/onc.2011.303 · Cited by 15
Rengucci, C., Maio, G. D., Gardini, A. C., Zucca, M., Scarpi, E., Zingaretti, C., Foschi, G., Tumedei, M. M., Molinari, C., Saragoni, L., et al. (2014) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-014-0065-x · Cited by 15
Role of leukemia inhibitory factor in nasopharyngeal carcinogenesis
Liu, S., & Chang, Y. (2014) · Molecular & Cellular Oncology · doi:10.4161/mco.29900 · Cited by 15
Altered corticomotor‐cerebellar integrity in young ataxia telangiectasia patients
Sahama, I., Sinclair, K., Fiori, S., Pannek, K., Lavin, M. F., & Rose, S. (2014) · Movement Disorders · doi:10.1002/mds.25970 · Cited by 15
Self-citationMolecular genetic characterization ofDrosophilaATM conserved functional domains
Pedersen, M., Tiong, S. Y. K., & Campbell, S. D. (2010) · Genome · doi:10.1139/g10-067 · Cited by 16
Zhang, J., Ooi, J., Utami, K. H., Langley, S. R., Aning, O. A., Park, D. S., Renner, M., Ma, S., Cheok, C. F., Knoblich, J. A., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/850586 · Cited by 20
Somatic and germline ATM variants in non-small-cell lung cancer: Therapeutic implications
Hernandez‐Martinez, J., Rosell, R., & Arrieta, O. G. (2023) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2023.104058 · Cited by 17
Beyraghi‐Tousi, M., Sahebkar, A., Houra, M., Sarvghadi, P., Jamialahmadi, T., Bagheri, R., Tavallaie, S., Gumpricht, E., & Saberi‐Karimian, M. (2024) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2024.04.009 · Cited by 15
Inhibitors of DNA double-strand break repair at the crossroads of cancer therapy and genome editing
Ray, U., & Raghavan, S. C. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.114195 · Cited by 16
Combinations of Low-Frequency Genetic Variants Might Predispose to Familial Pancreatic Cancer
Slater, E. P., Wilke, L. M., Böhm, L. B., Strauch, K., Lutz, M., Krasser‐Gercke, N., Matthäi, E., Hemminki, K., Försti, A., Schlesner, M., et al. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11070631 · Cited by 14
DNA damage response and repair in the development and treatment of brain tumors
Dana, P. M., Sadoughi, F., Mirzaei, H., Asemi, Z., & Yousefi, B. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2022.174957 · Cited by 15
Hathcock, K. S., Bowen, S., Livák, F., & Hodes, R. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062188 · Cited by 15
Darrah, E. J., Kulinski, J. M., Mboko, W. P., Xin, G., Malherbe, L. P., Gauld, S. B., Cui, W., & Tarakanova, V. L. (2017) · Journal of Virology · doi:10.1128/jvi.01103-17 · Cited by 14
PIKK ing a way to regulate inflammation
Quek, H., Lim, Y. C., Lavin, M. F., & Roberts, T. L. (2017) · Immunology and Cell Biology · doi:10.1111/imcb.1001 · Cited by 18
Self-citationAtaxia-telangiectasia: A new remitting form with a peculiar transcriptome signature
Leuzzi, V., D’Agnano, D., Menotta, M., Caputi, C., Chessa, L., & Magnani, M. (2018) · Neurology Genetics · doi:10.1212/nxg.0000000000000228 · Cited by 14
“Ataxia-telangiectasia (AT; OMIM#208900) is a rare genetic disease caused by mutations in the AT-mutated (ATM) gene encoding PI3kinase, which controls the cell cycle and DNA repair.(1) Patients with classic AT present with early-onset progressive cerebellar ataxia, oculocutaneous telangiectasias, immunodeficiency, late…”
Cho, S. O., Lim, J. W., & Kim, H. (2019) · Free Radical Research · doi:10.1080/10715762.2019.1655145 · Cited by 15
DDIT4 gene expression is switched on by a new HDAC4 function in ataxia telangiectasia
Ricci, A., Galluzzi, L., Magnani, M., & Menotta, M. (2019) · The FASEB Journal · doi:10.1096/fj.201902039r · Cited by 16
Changes in leukocyte gene expression profiles induced by antineoplastic chemotherapy
González-Fernández, R., Morales, M., Ávila, J., & Martı́n-Vasallo, P. (2012) · Oncology Letters · doi:10.3892/ol.2012.669 · Cited by 14
Chen, W., Chen, Z., Jia, Y., Guo, Y., Zheng, L., Yao, S., Shao, Y., Li, M., Mao, R., & Jiang, Y. (2024) · Environment International · doi:10.1016/j.envint.2024.108515 · Cited by 13
Roles of leukemia inhibitory factor receptor in cancer
Ma, W., Yan, H., Ma, H., Xu, Z., Dai, W., Wu, Y., Zhang, H., & Li, Y. (2024) · International Journal of Cancer · doi:10.1002/ijc.35157 · Cited by 14
ATM is required for the repair of Topotecan-induced replication-associated double-strand breaks
Köcher, S., Spies-Naumann, A., Kriegs, M., Dahm‐Daphi, J., & Dornreiter, I. (2013) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2013.06.024 · Cited by 14
Role of NBS1 in DNA damage response and its relationship with cancer development
Saito, Y., Fujimoto, H., & Kobayashi, J. (2013) · Translational Cancer Research · doi:10.21037/1097 · Cited by 19
Dissecting the role of TP53 alterations in del(11q) chronic lymphocytic leukemia
Quijada‐Álamo, M., Carretero, C. P., Hernández‐Sánchez, M., Rodríguez‐Vicente, A. E., Herrero, A. B., Hernández‐Sánchez, J., Martín‐Izquierdo, M., Santos‐Mínguez, S., Rey, M. D., González, T., et al. (2021) · Clinical and Translational Medicine · doi:10.1002/ctm2.304 · Cited by 14
Lee, A. B. C., Tan, M. H., & Chai, C. L. L. (2022) · Drug Discovery Today · doi:10.1016/j.drudis.2022.06.006 · Cited by 13
Ludwig, L. B., Valiati, V. H., Palazzo, R. P., Jardim, L. B., da Rosa, D. P., Bona, S., Rodrigues, G. S., Marroni, N. P., Prá, D., & Maluf, S. W. (2013) · BioMed Research International · doi:10.1155/2013/762048 · Cited by 13
Li, X., O’Neil, N. J., Moshgabadi, N., & Hieter, P. (2014) · Genetics · doi:10.1534/genetics.114.161307 · Cited by 14
Ataxia telangiectasia: The consequences of a delayed diagnosis
Mandigers, C. M. P. W., van de Warrenburg, B. P. C., Strobbe, L. J. A., Kluijt, I., Molenaar, A. H. M., & Schinagl, D. A. X. (2011) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2011.02.007 · Cited by 17
MET signaling promotes DNA repair and radiation resistance in glioblastoma stem-like cells
Todorova, P. K., Mukherjee, B., & Burma, S. (2017) · Annals of Translational Medicine · doi:10.21037/atm.2017.01.67 · Cited by 13
Targeting DNA repair in gliomas
Beckta, J. M., Bindra, R. S., & Chalmers, A. J. (2019) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000760 · Cited by 13
Richardson, E., Stockwell, S. R., Li, H., Aherne, W., Cuomo, M. E., & Mittnacht, S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031627 · Cited by 16
Lim, A. M. L., Young, R. J., Collins, M. L., Fox, S. B., McArthur, G. A., Corry, J. F., Peters, L., Rischin, D., & Solomon, B. (2012) · Oral Oncology · doi:10.1016/j.oraloncology.2012.02.014 · Cited by 15
Effects of p21 deletion in mouse models of premature aging
Benson, E. K., Zhao, B., Sassoon, D. A., Lee, S. W., & Aaronson, S. A. (2009) · Cell Cycle · doi:10.4161/cc.8.13.8997 · Cited by 16
Clinical histopathology and pathogenesis of macular telangiectasia type 2
Ntentakis, D. P., Ntentaki, A. M., Delavogia, E., Sakuno, G., Correa, V., Efstathiou, N. E., Aronow, M. E., Chew, E. Y., Miller, J. W., & Vavvas, D. G. (2025) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2025.101401 · Cited by 14
Im, C., Kim, B. M., Moon, E., Hong, D., Park, J. W., & Hong, S. H. (2013) · Genomics & Informatics · doi:10.5808/gi.2013.11.4.245 · Cited by 12
NRF2 Mediates Cellular Resistance to Transformation, Radiation, and Inflammation in Mice
Schaue, D., Micewicz, E. D., Ratikan, J. A., Iwamoto, K. S., Vlashi, E., McDonald, J. T., & McBride, W. H. (2022) · Antioxidants · doi:10.3390/antiox11091649 · Cited by 12
Genome integrity and inflammation in the nervous system
Aditi, A., & McKinnon, P. J. (2022) · DNA repair · doi:10.1016/j.dnarep.2022.103406 · Cited by 14
Molecular Imaging of the ATM Kinase Activity
Williams, T. M., Nyati, S., Ross, B. D., & Rehemtulla, A. (2013) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2013.04.028 · Cited by 12
Čejková, S., Ročňová, L., Potěšil, D., Šmardová, J., Novakova, V., Chumchalová, J., Žežulková, D., Borský, M., Doubek, M., Brychtová, Y., et al. (2008) · European Journal Of Haematology · doi:10.1111/j.1600-0609.2008.01177.x · Cited by 12
Proteasome-dependent degradation of replisome components regulates faithful DNA replication
Roseaulin, L., Noguchi, C., & Noguchi, E. (2013) · Cell Cycle · doi:10.4161/cc.25692 · Cited by 12
Yamaguchi, Y., Takenobu, H., Ohira, M., Nakazawa, A., Yoshida, S., Akita, N., Shimozato, O., Iwama, A., Nakagawara, A., & Kamijo, T. (2014) · European Journal of Cancer · doi:10.1016/j.ejca.2014.01.023 · Cited by 12
AT cells are not radiosensitive for simple chromosomal exchanges at low dose
Hada, M., Huff, J. L., Patel, Z. S., Kawata, T., Pluth, J. M., George, K. A., & Cucinotta, F. A. (2011) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2011.08.006 · Cited by 13
Verduzco, D., Dovey, J. S., Shukla, A. A., Kodym, E., Skaug, B. A., & Amatruda, J. F. (2012) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-12-0072 · Cited by 12
Amirifar, P., Yazdani, R., Shad, T. M., Ghanadan, A., Abolhassani, H., Lavin, M. F., Sotoudeh, S., & Aghamohammadi, A. (2019) · Immunological Investigations · doi:10.1080/08820139.2019.1692864 · Cited by 12
Self-citationXu, Y. Y., Zhao, X., Liu, J., Wang, Y., Xiong, L.-L., He, X., & Wang, T. (2019) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-019-02337-5 · Cited by 13
Sp, N., Kang, D. Y., Jo, E. S., Lee, J., Bae, S. W., & Jang, K. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.781720 · Cited by 13
Biagiotti, S., Menotta, M., Giacomini, E., Radici, L., Bianchi, M., Bozzao, C., Chessa, L., & Magnani, M. (2014) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-014-2013-7 · Cited by 12
Wilson, P. F., Nagasawa, H., Fitzek, M. M., Little, J. B., & Bedford, J. S. (2009) · Radiation Research · doi:10.1667/rr1943.1 · Cited by 12
Studying the cerebellar DNA damage response in the tissue culture dish
Tzur-Gilat, A., Ziv, Y., Mittelman, L. A., Barzilai, A., & Shiloh, Y. (2013) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2013.04.001 · Cited by 13
Growth hormone treatment in patients with ataxia telangiectasia
Woelke, S., Pommerening, H., Kieslich, M., Schubert, R., & Zielen, S. (2017) · Growth Factors · doi:10.1080/08977194.2017.1367681 · Cited by 12
“ATM is a serine/ threonine protein kinase that mediates activation of multiple signalling pathways following the induction of DNA double-strand breaks and oxidative stress (Lavin, 2008).”
InfluentialEvaluation of fetal cell transplantation safety in treatment of diabetes: a three-year follow-up
Nasli‐Esfahani, E., Ghodsi, M., Amini, P., Keshtkar, A., Amiri, S., Yazdi, N. M., Tootee, A., & Larijani, B. A. (2015) · Journal of Diabetes & Metabolic Disorders · doi:10.1186/s40200-014-0126-x · Cited by 11
Karamat, U., & Ejaz, S. (2020) · Current Cancer Drug Targets · doi:10.2174/1568009620666201009125507 · Cited by 12
Dynamic recruitment of UFM1-specific peptidase 2 to the DNA double-strand breaks regulated by WIP1
Qin, B., Yu, J., Zhao, F., Huang, J., Zhou, Q., & Lou, Z. (2022) · Genome Instability & Disease · doi:10.1007/s42764-022-00076-z · Cited by 13
A Role for ATM in Hereditary Pancreatic Cancer
Bakker, J. L., & de Winter, J. P. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-11-0318 · Cited by 11
Bucher, M., Endesfelder, D., Roessler, U., Borkhardt, A., Dückers, G., Kirlum, H., Lankisch, P., Oommen, P. T., Niehues, T., Rübe, C. E., et al. (2020) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/j.mrgentox.2020.503301 · Cited by 15
Growth hormone supplementation increased latency to tumourigenesis inAtm-deficient mice
Schubert, R., Schmitz, N., Pietzner, J., Tandi, C., Theisen, A., Dresel, R., Christmann, M., & Zielen, S. (2009) · Growth Factors · doi:10.1080/08977190903112663 · Cited by 12
14-3-3σ and p21 synergize to determine DNA damage response following Chk2 inhibition
Meng, S., Arbit, T., Veeriah, S., Mellinghoff, I. K., Fang, F., Vivanco, I., Rohle, D., & Chan, T. A.-T. (2009) · Cell Cycle · doi:10.4161/cc.8.14.8998 · Cited by 11
Turinetto, V., Porcedda, P., Minieri, V., Orlando, L., Lantelme, E., Accomasso, L., Amoroso, A., Marchi, M., Zannini, L., Delia, D., et al. (2010) · DNA repair · doi:10.1016/j.dnarep.2010.09.003 · Cited by 11
Hewitt, S. L., Wong, J. B., Lee, J., Nishana, M., Chen, H., Coussens, M., Arnal, S. M., Blumenberg, L. M., Roth, D. B., Paull, T. T., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.09.084 · Cited by 12
ATM facilitates mouse gammaherpesvirus reactivation from myeloid cells during chronic infection
Kulinski, J. M., Darrah, E. J., Broniowska, K. A., Mboko, W. P., Mounce, B. C., Malherbe, L. P., Corbett, J. A., Gauld, S. B., & Tarakanova, V. L. (2015) · Virology · doi:10.1016/j.virol.2015.04.026 · Cited by 11
Homeodomain Proteins Directly Regulate ATM Kinase Activity
Johnson, T. E., Lee, J., Myler, L. R., Zhou, Y., Mosley, T. J., Yang, S.-H., Uprety, N., Kim, J., & Paull, T. T. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.06.089 · Cited by 12
“Loss of functional ATM protein results in ataxia-telangiectasia, a pleiotropic disorder characterized by progressive neurodegeneration, predisposition to cancer, immunodeficiency, and sensitivity to DNA-damaging agents (Anheim et al., 2012; Lavin, 2008; Perlman et al., 2012; Shiloh and Ziv, 2013).”
BackgroundPeripheral neuropathies associated with DNA repair disorders
Maguina, M., Kang, P. B., Tsai, A., & Pacak, C. A. (2022) · Muscle & Nerve · doi:10.1002/mus.27721 · Cited by 10
Li, T., & Wang, Z. (2011) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2011.05.001 · Cited by 10
Mendez, G., Cilli, D., Berardinelli, F., Viganotti, M., Ascenzi, P., Tanzarella, C., Antoccia, A., & di Masi, A. (2012) · IUBMB Life · doi:10.1002/iub.1077 · Cited by 10
Functional Proteomics Analysis to Study ATM Dependent Signaling in Response to Ionizing Radiation
Cheema, A. K., Varghese, R. S., Timofeeva, O. A., Zhang, L., Kirilyuk, A., Zandkarimi, F., Kaur, P., Ressom, H. W., Jung, M., & Dritschilo, A. (2013) · Radiation Research · doi:10.1667/rr3198.1 · Cited by 11
Site promiscuity of coliphage HK022 integrase as a tool for gene therapy
Kolot, M. N., Malchin, N., Elias, A., Gritsenko, N., & Yagil, E. (2015) · Gene Therapy · doi:10.1038/gt.2015.9 · Cited by 12
CONGENITAL AND ACQUIRED IMMUNODEFICIENCIES
Abbas, A. K., Lichtman, A. H., Pillai, S. S., & Baker, D. L. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-3123-9.50029-2 · Cited by 10
Hirozane, T., Tohmonda, T., Yoda, M., Shimoda, M., Kanai, Y., Matsumoto, M., Morioka, H., Nakamura, M., & Horiuchi, K. (2016) · Scientific Reports · doi:10.1038/srep34426 · Cited by 12
Cell response to extremely weak static magnetic fields
Im, S., Kuranova, M. L., Mavropolo-Stolyarenko, G., Сурма, С. В., Щеголев, Б. Ф., & Стефанов, В. Е. (2016) · BIOPHYSICS · doi:10.1134/s0006350916030180 · Cited by 10
Phase separation of ERCC6L2–CtIP regulates the extent of DNA end resection
Yin, Y., Lin, J., Cai, X., Nie, R., Lin, J., Li, S., Xiang, Z., Ling, Y., Zhang, Y., Zhou, J., et al. (2025) · Nature Cell Biology · doi:10.1038/s41556-025-01760-4 · Cited by 13
“The ataxia telangiectasia mutated (ATM) kinase serves as a master regulator of the DNA damage response (DDR), coordinating HR and NHEJ by modulating DNA end resection 6–8 .”
Kiuru, A., Kämäräinen, M., Heinävaara, S. H., Pylkäs, K., Chapman, K. L., Koivistoinen, A., Parviainen, T., Winqvist, R., Kadhim, M. A., Launonen, V., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0093211 · Cited by 9
Ho, U. Y., Luff, J., James, A. C., Lee, C. S., Quek, H., Lai, H., Apte, S. H., Lim, Y. C., Lavin, M. F., & Roberts, T. L. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14685 · Cited by 10
Self-citationATM and ATR checkpoint kinase pathways: A concise review
Chauhan, N., Wagh, V., Joshi, P., & Jariyal, H. (2020) · Advances in Human Biology · doi:10.4103/aihb.aihb_78_19 · Cited by 11
Duecker, R. P., Gronau, L., Baer, P. C., Zielen, S., & Schubert, R. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.693897 · Cited by 9
CHK2 Promotes Metabolic Stress-Induced Autophagy through ULK1 Phosphorylation
Guo, R., Wang, S., Jiang, X.-Y., Zhang, Y., Guo, Y., Cui, H., Guo, Q., Cao, L., & Xie, X.-C. (2022) · Antioxidants · doi:10.3390/antiox11061166 · Cited by 10
New human ATM variants are able to regain ATM functions in ataxia telangiectasia disease
Ricci, A., Biancucci, F., Morganti, G., Magnani, M., & Menotta, M. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04625-3 · Cited by 11
Chandris, P., Giannouli, C. C., Panayotou, G., & Kletsas, D. (2010) · Biogerontology · doi:10.1007/s10522-010-9261-z · Cited by 10
'A mover and a shaker': 53BP1 allows DNA doublestrand breaks a chance to dance and unite
Goodarzi, A. A., & Jeggo, P. A. (2009) · F1000 Biology Reports · doi:10.3410/b1-21 · Cited by 11
Baranski, O. A., Kalinichenko, V. V., & Adami, G. R. (2014) · Cell Proliferation · doi:10.1111/cpr.12153 · Cited by 10
Identification of dAven, aDrosophila melanogasterortholog of the cell cycle regulator Aven
Zou, S., Chang, J. W., LaFever, L., Tang, W., Johnson, E. L., Hu, J., Wilk, R., Krause, H. M., Drummond‐Barbosa, D., & Irusta, P. M. (2011) · Cell Cycle · doi:10.4161/cc.10.6.15080 · Cited by 10
Vehlow, A., & Cordes, N. (2022) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1007/s11626-022-00656-z · Cited by 9
Zhang, Y., Ou, G., Ye, Z., Zhou, Z., Cao, Q., Li, M., Wang, J., Cao, J., & Yang, H. (2022) · iScience · doi:10.1016/j.isci.2022.105115 · Cited by 9
Sule, A. D., Golding, S. E., Ahmad, S. F., Watson, J., Ahmed, M. H., Kellogg, G. E., Bernaś, T., Koebley, S. R., Reed, J. C., Povirk, L. F., et al. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04550-5 · Cited by 10
Kim, C. D., Reed, R. E., Juncker, M. A., Fang, Z., & Desai, S. D. (2017) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlx038 · Cited by 9
A novel and simple micro-irradiation technique for creating localized DNA double-strand breaks
Suzuki, K., Yamauchi, M., Oka, Y., Suzuki, M., & Yamashita, S. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq226 · Cited by 12
A TRilogy of ATR’s Non-Canonical Roles Throughout the Cell Cycle and Its Relation to Cancer
Joo, Y. K., Ramírez, C. D., & Kabeche, L. (2024) · Cancers · doi:10.3390/cancers16203536 · Cited by 8
“…with additional conditions including: ataxia, telangiectasia, mental disabilities, and overall nervous system defects, all of which occur in tissues that are not considered highly proliferative, which seems paradoxical to the established role of ATR as a cell cycle checkpoint protein [13,21–28].”
BackgroundDrugging the DNA damage response in the clinic: going beyond PARP
Torrado, C., González-Ortiz, Á., Xavier, C. B., Tan, H. N., Ngoi, N. Y. L., & Yap, T. A. (2025) · Expert Review of Anticancer Therapy · doi:10.1080/14737140.2025.2575825 · Cited by 10
Zhou, J., Gu, L., Shi, Y., Huang, T. H., Fan, X., Bi, X., Lü, S., Liang, J., Luo, L., Cao, P., et al. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-021-04057-5 · Cited by 8
Exploring the DNA damage response pathway for synthetic lethality
Xu, X., Nowsheen, S., & Deng, M. (2022) · Genome Instability & Disease · doi:10.1007/s42764-022-00087-w · Cited by 9
Bass, T. E., Fleenor, D. E., Burrell, P. E., & Kastan, M. B. (2022) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-22-0399 · Cited by 8
Jin, Y., Li, Y., He, S., Ge, Y., Zhao, Y., Zhu, K., He, A., Li, S., Yan, S., & Cao, C. (2023) · Environmental Toxicology · doi:10.1002/tox.23901 · Cited by 8
“14 ATM is regarded as an important initiator and regulator for DNA damage and DDR, respectively.”
Background
Metadata
- Authors
- Lavin, M. F.
- Affiliations
- QIMR Berghofer Medical Research Institute (AU)
- Corresponding author
- Lavin, Martin F.
- ORCID
- Lavin, Martin F.
- Venue
- Nature Reviews Molecular Cell Biology
- Published
- 2008-10
- Volume
- 9
- Issue
- 10
- Pages
- 759-769
- ISSN
- 1471-0072 (ISSN-L)
- 1471-0080
- OpenAlex
- W2139777089
- Cited by
- 901
- References
- 126
- Citations by year
- 2026: 15 · 2025: 16 · 2024: 17 · 2023: 19 · 2022: 36 · 2021: 43 · 2020: 36 · 2019: 42 · 2018: 26 · 2017: 54 · 2016: 50 · 2015: 45 · 2014: 63 · 2013: 76 · 2012: 90
- FWCI
- 6.70
- Type
- journal article
- Language
- en
- Update notices
- erratum (2008-12-01)
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Reviews Molecular Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › BRCA gene mutations in cancer
- Keywords
- ataxia telangiectasia, ATM protein, DNA damage response, genomic instability, cancer susceptibility, neurodegenerative diseases, signal transduction, cell cycle regulation
- MeSH terms
- Animals, Ataxia Telangiectasia, DNA Damage, DNA Repair, DNA-Binding Proteins, Humans, Insulin Resistance, Models, Biological, Mutation, Neoplasms, Nerve Degeneration, Protein Processing, Post-Translational, Signal Transduction, Protein Serine-Threonine Kinases, Cell Cycle Proteins, Genetic Predisposition to Disease, Metabolic Syndrome, Tumor Suppressor Proteins, Mice, Ataxia Telangiectasia Mutated Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.